IDBS launches Polar BioAnalysis
The launch extends the Polar BioPharma Lifecycle Management (BPLM) platform with best practices in preclinical drug qualification
26 Mar 2021
IDBS, one of the leading innovators in BioPharma Lifecycle Management (BPLM), has announced the launch of Polar BioAnalysis, promising consistency, quality, and reproducibility to preclinical drug qualification.
Polar BioAnalysis expands the capabilities of IDBS Polar, a cloud-based platform designed to solve workflow, quality, and data analysis challenges across the entire development lifecycle. By combining the Polar platform with out-of-the-box workflows based on more than 25 years’ of experience, Polar BioAnalysis enables companies to improve quality and reproducibility, reduce study cycle times and accelerate time-to-market.
Polar BioAnalysis workflows cover planning, execution, and analysis, all linked together with a robust data model. Planning workflows allow Study Directors and Principal Investigators to define the recipes, procedures and parameters of the methods and assays that will be conducted, ensuring that execution is repeatable. Execution workflows allow laboratory-based users to conduct the procedures and preparations of bioanalysis, ensuring quality while retaining flexibility. Reporting workflows summarize results across the execution workflows within a study, highlighting areas that require further investigation and making it easier to investigate.
This approach supports ICH M10 compliance, eliminates the majority of common deviations, and can reduce overall study duration by more than 50%. Quick access to necessary information has also been demonstrated to support FDA audits, enabling audit questions to be answered and resolved promptly.
“The customer demand for BPLM necessitates a new product category and IDBS’ strength in preclinical work presented an opportunity to bring our bioanalysis experience into the Polar platform,” said Graeme Dennis, Commercial Director, Preclinical Biopharma at IDBS. “We can support regulatory and operational considerations, and carry high-quality data forward for insight and reporting. That data becomes contextualized within the development lifecycle. And that’s exactly what we want Polar BioAnalysis to do for our customers.”
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Related Products
Request Quote for All Products
ActivityBase Suite
IDBSIDBS ActivityBase - Capture, store, secure, analyze and share discovery data The IDBS ActivityBase suite provides efficient and effective drug discovery data management, enabling scientists to work more productively and saving life sciences organizations time and money. From high volume, routine screening through to low throughput data management, ActivityBase provides a secure, consistent and accessible environment for a drug discovery organization's most vital asset - data. The IDBS ActivityBase Suite includes: ActivityBase for Biologists - flexible experiment definition, reliable experimental data capture, manipulation and analysis, and configurable workflow management. ActivityBase for Chemists - structure registration, searching and display in a chemically aware environment that also provides biological data management. ActivityBase for Screeners - optimized workflow for high throughput and ultra high throughput screening.SARview - delivers dynamic SAR reports that facilitate the investigation of relationships between biological activity and chemical structure, enhancing scientific communication